Dendritic cells and tumor microenvironment: a dangerous liaison
about
Targeted immune therapy of ovarian cancerMyeloid-derived cells are key targets of tumor immunotherapyOrchestration of angiogenesis by immune cellsMinireview: Regulatory T Cells and Ovarian Cancer.Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumoursTherapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.The tumor microenvironment in colorectal carcinogenesis.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune responseImmunity and immune suppression in human ovarian cancer.Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression?Effect of siRNA-mediated downregulation of VEGF in Tca8113 cells on the activity of monocyte-derived dendritic cells.Lung cancer: Biology and treatment options.Clinical opportunities in combining immunotherapy with radiation therapy.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.The tumor microenvironment and its role in promoting tumor growth.Advancements in immune toleranceTLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance.Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells.The immune system in the pathogenesis of ovarian cancer.The impact of the immune system on tumor: angiogenesis and vascular remodeling.TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo.Mechanism of immune evasion in breast cancer.Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced toleranceAutophagy and cancer.Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells.Tumor associated regulatory dendritic cells.Homeostatic chemokines guide lymphoma cells to tumor growth-promoting niches within secondary lymphoid organs.Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.Dendritic cell defects in the colorectal cancerT Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1.Wnt5a inhibits human monocyte-derived myeloid dendritic cell generation.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Modern strategies and capabilities for activation of the immune response against tumor cells.c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model.
P2860
Q28082828-DC124B56-244A-4C44-8ED7-26B4F4885F43Q28388246-0DC8C81E-4D09-45DC-9A80-2D48E0392CCAQ28389236-DB30B6E9-6E97-41C0-BF0D-256E6115F397Q30244214-7ECABAE0-9BC9-4EFC-A06E-CD8ADB4D6492Q33276145-46B8F6BC-64BB-44B5-8BE2-03716C3F5980Q33730717-69560AA1-BBF1-4CE5-9BE0-1BA04509D962Q33919954-9FF6BB70-F907-49C3-9EE2-34177548BA62Q34343645-38D036F2-A7A8-4D24-BEDF-B680F8BF08FEQ34557233-FD12AACF-3EF5-467B-96E2-B2A63C863BD4Q35043529-9EEF8BF3-E69F-4931-8802-3A275C62D7D2Q35138135-1204C8EA-B54F-4868-98E8-FB4A5F54A260Q35584599-CEBAD162-5336-4163-86A3-660B59BA3C45Q35995289-33533E73-0CC8-4266-87A1-F7761536223CQ36328370-132E6409-98F1-482A-961B-8E205ED5126FQ36449873-0ABFD12A-8475-4B7C-9A04-91F4D896F4BDQ36821053-C1B53A3B-D295-40E6-BF61-2E2E2F102E19Q36946019-D6DAB199-49E2-443E-8128-888A186918B9Q36988746-5A4E301D-A5A6-4284-A6C0-6FFFD056C3D6Q37051003-D5C0CDF2-F958-411B-AC0E-18E066003F47Q37212043-766A3314-A868-457A-B1A3-FEA2893841ACQ37291308-84F4652D-6DD7-49D4-B0DB-325EC28B686CQ37613407-CD4972C6-0A49-4EE9-9E98-AE555AA6C429Q37702536-DD5BA698-673F-4A5E-95E6-F23F3740E6C0Q37706972-7272E559-3CAB-4B1E-AD9A-5C5B7090E276Q37712385-9E1BB423-E2F8-4A02-97E7-F9509CCB7B31Q37758250-90C9BA2E-8929-4BD6-86A5-CEA47FE134F1Q37822746-A6A418A3-83F6-483F-8DC1-9A5EEEB91931Q37959968-7681F554-BA0B-4A11-BEC1-07952B53B57AQ37967998-120FE6D2-D6B1-4D6E-9AB7-7E37515FD1E4Q37975160-BD803ED0-DC3D-4585-BB92-F15466F39998Q37993359-705FE612-628F-49FF-BEE7-42172379F534Q38009278-1086B6B7-B665-44D3-9B1E-2D07BDCD66D6Q38047053-F91C9BE1-E520-46C3-B31C-D262EB59E330Q38284706-79D5F888-6BA7-4B0F-8315-20F183ABF32DQ38825933-A6B1BF6E-701B-453D-B871-3826FD466479Q39151209-D3DBA514-3F31-46B3-BD99-58996F436E74Q39202332-BCF4A7F9-46F0-4FD1-9705-6981CDA1EEC6Q39312666-71BF8E3A-1B94-4EF5-9319-A34EF1905FD4Q39579445-AD232E9A-A44B-4D8C-91C3-47F9D5275204Q40118206-891BEC4A-8591-4924-8B7C-F9F190A5F06C
P2860
Dendritic cells and tumor microenvironment: a dangerous liaison
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Dendritic cells and tumor microenvironment: a dangerous liaison
@ast
Dendritic cells and tumor microenvironment: a dangerous liaison
@en
type
label
Dendritic cells and tumor microenvironment: a dangerous liaison
@ast
Dendritic cells and tumor microenvironment: a dangerous liaison
@en
prefLabel
Dendritic cells and tumor microenvironment: a dangerous liaison
@ast
Dendritic cells and tumor microenvironment: a dangerous liaison
@en
P2860
P1476
Dendritic cells and tumor microenvironment: a dangerous liaison
@en
P2093
Dmitry I Gabrilovich
Ingo Fricke
P2860
P304
P356
10.1080/08820130600803429
P577
2006-01-01T00:00:00Z